Literature DB >> 4946010

Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).

G P Bodey, V Rodriguez, J Hart, E J Freireich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4946010

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.

Authors:  J A Zix; H F Geerdes-Fenge; M Rau; J Vöckler; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside.

Authors:  T Büchner; B Barlogie; U Asseburg; W Hiddemann; D Kamanabroo; W Göhde
Journal:  Blut       Date:  1974-04

3.  Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.

Authors:  J L Poth; P K Johnson; R P George; S L Schrier
Journal:  Calif Med       Date:  1972-12

4.  Remission-induction regimens in acute nonlymphocytic leukemia.

Authors:  D C Brennan; J P Lewis
Journal:  West J Med       Date:  1980-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.